US launches, cost checks drive Ranbaxy's growth in fourth quarter
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has bounced back into the black during the fourth quarter ended December 31st, 2009, with a net profit of $54 million, as against a loss of $142 million in the same quarter of the previous year.